Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor

Provided By PR Newswire

Last update: Jul 12, 2022

Acorn Management Partners Will Develop and Implement a Market Awareness Program Targeting Financial Professionals

TORRANCE, Calif., July 12, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the recent engagement of Acorn Management Partners, LLC to provided professional relations and consulting services to build investor awareness of Emmaus.